… immune responses during COVID-19, we suggest that type I interferon (IFN) could be
administered to patients with severe COVID-19 … administered in the immune hyperactivation stage. …

… immune responses may play an equally important role in the pathogenesis, clinical manifestation,
and outcomes of COVID-19. … Immune modulators have the potential to inhibit cytokines …

… Antiviral agents and immune modulating treatments are currently being trialled. Understanding
immune evasion strategies of SARS-CoV2 and the resulting delayed massive immune …

… immune dysregulation in inducing multiorgan damage. Therefore, the potential benefits of
both immune modulation and suppression in COVID-19 … potential COVID-19 pharmacological …

… rates among the severely ill COVID-19 patients, effective and earlier regulation of the cytokine
storm using treatments including immune suppressants, immune modulators, and cytokine …

… COVID-19 therapeutics, including repurposed drugs, vaccine candidates, immune-modulators, …
reduce the cost and duration of anti-COVID-19 drug development. Gene/protein-based …

… What would happen if we start or initiate treatment of moderate to severe patients of
COVID-19 by immune modulators with the support of antibiotics, dexamethasone, and other …

… This review provides an overview of current knowledge on COVID-19 … in severe COVID-19
(ie interleukin-1β-driven macrophage activation syndrome vs. interleukin-6-driven immune …

… is harmful to patients in the context of COVID-19. COVID-19 has been observed to induce a
… of IL-6 inhibitors on the modulation of COVID-19. Although there are potential targets in the …

… cell activation and phenotype against lupus erythematosus 49 , which indicates its possible
impact on the modulation of host immune response during SARS-CoV-2 infection 50,51,52 . …